Home/Filings/4/0001415889-25-011227
4//SEC Filing

Farnum Rhonda 4

Accession 0001415889-25-011227

CIK 0001583107other

Filed

Apr 22, 8:00 PM ET

Accepted

Apr 23, 6:00 PM ET

Size

4.7 KB

Accession

0001415889-25-011227

Insider Transaction Report

Form 4
Period: 2025-04-21
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Transactions
  • Sale

    Ordinary Shares

    2025-04-21$9.00/sh4,000$36,000370,038 total

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001898490

Filing Metadata

Form type
4
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 6:00 PM ET
Size
4.7 KB